Trial Profile
A Study of a Long-Term Administration of JNS013 in Patients With Chronic Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jul 2013
Price :
$35
*
At a glance
- Drugs Tramadol/paracetamol (Primary)
- Indications Diabetic neuropathies; Musculoskeletal pain; Neuropathic pain; Postherpetic neuralgia; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 16 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 May 2009 Actual patient number (139) added as reported by ClinicalTrials.gov.